MRL for rafoxanide in food of animal origin
- Food safety
- Veterinary residues
Summary
The EU has introduced a maximum residue level (MRL) for rafoxanide in milk from cattle and sheep. In addition, the existing MRLs for rafonaxide in muscle, fat, liver, and kidney of cattle now apply to all ruminants except sheep.
Introduction of MRL for rafoxanide in milk from cattle and sheep
Commission Implementing Regulation (EU) 2023/2203 of 20 October 2023 amending Regulation (EU) No 37/2010 as regards the classification of the substance rafoxanide with respect to its maximum residue limit in foodstuffs of animal origin
Update
The EU has introduced a maximum residue level (MRL) for rafoxanide in milk from cattle and sheep. In addition, the existing MRLs for rafonaxide in muscle, fat, liver, and kidney of cattle now apply to all ruminants except sheep.
Impacted Products
muscle, fat, liver, and kidney of ruminants except sheep; milk from cattle and sheep
What is changing?
The European Commission is introducing an MRL for the antiparasitic agent rafoxanide in milk from cattle and sheep at 10 μg/kg.
In addition, the MRLs for rafoxanide in cattle – for muscle and fat (30 μg/kg), liver (10 μg/kg), and kidney (40 μg/kg) – now apply to all ruminants except sheep.
The Annex to Regulation 37/2010 on pharmacologically active substances and their MRLs in food of animal origin will be amended accordingly.
Why?
Based on a request from the Republic of Ireland, the European Medicines Agency recommended a definitive MRL for rafoxanide in milk from cattle and sheep.
The Agency also concluded that the existing MRLs for rafoxanide in muscle, fat, liver, and kidney from cattle can be extrapolated to all ruminants except sheep.
Timeline
Date of application: 12 November 2023.
What are the major implications for exporting countries?
Rafoxanide is now allowed in milk from cattle and sheep within the maximum limit of 10 μg/kg. The limits set for muscle, fat, liver, and kidney from cattle are extended to all ruminants except sheep.
Recommended Actions
Countries that export muscle, fat, liver, kidney, or milk from cattle and sheep must ensure that the established residue limits of rafonaxide in those products destined for the EU are not exceeded.
Background
Rafoxanide is an antiparasitic agent that can be used against endoparasites in cattle and sheep. The provisional MRL for rafoxanide for milk from cattle and sheep at 10 μg/kg expired on 31 December 2017.
Resources
European Commission (2023) Control plans for residues of veterinary medicines, pesticides and contaminants.
European Commission: Residues of veterinary medicinal products
European Medicines Agency: Maximum residue limits (MRL)
Sources
Disclaimer: Under no circumstances shall COLEAD be liable for any loss, damage, liability or expense incurred or suffered that is claimed to have resulted from the use of information available on this website or any link to external sites. The use of the website is at the user’s sole risk and responsibility. This information platform was created and maintained with the financial support of the European Union. Its contents do not, however, reflect the views of the European Union.
Introduction of MRL for rafoxanide in milk from cattle and sheep
Regulation
Regulation 2023/2203 as regards the classification of the substance rafoxanide with respect to its maximum residue limit in foodstuffs of animal origin
Regulation 37/2010 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin
What is changing and why?
Rafoxanide is an antiparasitic agent that can be used against endoparasites in cattle and sheep. Following a request from the Republic of Ireland, maximum residue limits (MRLs) for rafoxanide in milk from cattle and sheep are set at 10 μg/kg.
In addition, the MRLs for rafoxanide in cattle (30 μg/kg for muscle and fat; 10 μg/kg for liver; and 40 μg/kg for kidney) now apply to all ruminants except sheep.
Actions
Countries that export muscle, fat, liver, kidney, or milk from cattle and sheep must ensure that the established residue limits of rafonaxide in those products destined for the EU are not exceeded.
Timeline
Date of application: 12 November 2023.
Disclaimer: Under no circumstances shall COLEAD be liable for any loss, damage, liability or expense incurred or suffered that is claimed to have resulted from the use of information available on this website or any link to external sites. The use of the website is at the user’s sole risk and responsibility. This information platform was created and maintained with the financial support of the European Union. Its contents do not, however, reflect the views of the European Union.